Next Article in Journal
Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV
Next Article in Special Issue
Understanding Diversity of Policies, Functionalities, and Operationalization of Immunization Information Systems and Their Impact: A Targeted Review of the Literature
Previous Article in Journal
Optimizing the Production of gp145, an HIV-1 Envelope Glycoprotein Vaccine Candidate and Its Encapsulation in Guanosine Microparticles
Previous Article in Special Issue
The Polymorphic Membrane Protein G Has a Neutral Effect and the Plasmid Glycoprotein 3 an Antagonistic Effect on the Ability of the Major Outer Membrane Protein to Elicit Protective Immune Responses against a Chlamydia muridarum Respiratory Challenge
 
 
Article

Article Versions Notes

Vaccines 2023, 11(5), 976; https://doi.org/10.3390/vaccines11050976
Action Date Notes Link
article xml file uploaded 12 May 2023 14:22 CEST Original file -
article xml uploaded. 12 May 2023 14:22 CEST Update https://www.mdpi.com/2076-393X/11/5/976/xml
article pdf uploaded. 12 May 2023 14:22 CEST Version of Record https://www.mdpi.com/2076-393X/11/5/976/pdf
article supplementary file uploaded. 12 May 2023 14:22 CEST - https://www.mdpi.com/2076-393X/11/5/976#supplementary
article html file updated 12 May 2023 14:24 CEST Original file https://www.mdpi.com/2076-393X/11/5/976/html
Back to TopTop